VEGF receptors and neuropilins are expressed in the urothelial and neuronal cells in normal mouse urinary bladder and are upregulated in inflammation
Authors:
- Joseph M. BackerJBJoseph M. Backer
- Marina V. BackerMBMarina V. Backer
- Julie MaierJMJulie Maier
- Ben FowlerBFBen Fowler
- Carole A. DavisCDCarole A. Davis
- Cindy SimpsonCSCindy Simpson
- Xue-Ru WuXWXue-Ru Wu
- Lori BirderLBLori Birder
- Michael R. FreemanMFMichael R. Freeman
- Shay SokerSSShay Soker
- Robert E. HurstRHRobert E. Hurst
- 1 July 2008
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 295 (1) , F60-F72
Abstract
Recent evidence supports a role for vascular endothelium growth factor (VEGF) signaling in bladder inflammation. However, it is not clear what bladder cells are targeted by VEGF. Therefore, we determined the nature of cells responding to VEGF in normal and inflamed bladders by tagging such cells in vivo with a targeted fluorescent tracer, scVEGF/Cy, an engineered single-chain VEGF labeled with Cy5.5 dye, which identifies cells with accessible and functionally active VEGF receptors. Inflammation was induced by intravesical instillation of PAR-activating peptides or BCG. In vivo NIRF imaging with intravenously injected scVEGF/Cy revealed accumulation of the tracer in the control mouse bladder and established that inflammation increased the steady-state levels of tracer uptake. Ex vivo colocalization of Cy5.5 dye revealed that in normal and at a higher level in inflamed bladder, accumulation of scVEGF/Cy occurs in both urothelial and ganglial cells, expressing VEGF receptors VEGFR-1 and VEGFR-2, as well as VEGF coreceptors neuropilins (NRP) NRP1 and NRP2. PCR results indicate that the messages for VEGF-Rs and NRPs are present in the bladder mucosa and ChIP/QPCR analysis indicated that inflammation induced upregulation of genes encoding VEGFRs and NRPs. Our results strongly suggest new and blossoming VEGF-driven processes in bladder urothelial cells and ganglia in the course of inflammation. We expect that molecular imaging of the VEGF pathway in the urinary tract by receptor-mediated cell tagging in vivo will be useful for clinical diagnosis and therapeutic monitoring, and will help to accelerate the development of bladder-targeting drugs and treatments.Keywords
This publication has 43 references indexed in Scilit:
- Angiogenesis markers (VEGF, soluble receptor of VEGF and angiopoietin-1) in very early arthritis and their association with inflammation and joint destructionClinical Immunology, 2007
- Vascular Endothelial Growth Factor Mediates Hypoxic Stimulated Embryonic Bladder Growth in Organ CultureJournal of Urology, 2007
- A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2Cellular and Molecular Life Sciences, 2006
- Semaphorin 3A displays a punctate distribution on the surface of neuronal cells and interacts with proteoglycans in the extracellular matrixMolecular and Cellular Neuroscience, 2005
- Gene Discovery in Bladder Cancer Progression using cDNA MicroarraysThe American Journal of Pathology, 2003
- Expression of Protease-Activated Receptor-1, -2, -3, and -4 in Control and Experimentally Inflamed Mouse BladderThe American Journal of Pathology, 2003
- Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disordersSeminars in Cell & Developmental Biology, 2002
- Functionally Active VEGF Fusion ProteinsProtein Expression and Purification, 2001
- Expression of vascular endothelial growth factor receptors in smooth muscle cellsJournal of Cellular Physiology, 2001
- Large scale purification and immunolocalization of bovine uroplakins I, II, and III. Molecular markers of urothelial differentiation.Journal of Biological Chemistry, 1990